Literature DB >> 26790477

Effects of Dexamethasone on Satellite Cells and Tissue Engineered Skeletal Muscle Units.

Brian C Syverud1, Keith W VanDusen2, Lisa M Larkin1,2.   

Abstract

Tissue engineered skeletal muscle has potential for application as a graft source for repairing soft tissue injuries, a model for testing pharmaceuticals, and a biomechanical actuator system for soft robots. However, engineered muscle to date has not produced forces comparable to native muscle, limiting its potential for repair and for use as an in vitro model for pharmaceutical testing. In this study, we examined the trophic effects of dexamethasone (DEX), a glucocorticoid that stimulates myoblast differentiation and fusion into myotubes, on our tissue engineered three-dimensional skeletal muscle units (SMUs). Using our established SMU fabrication protocol, muscle isolates were cultured with three experimental DEX concentrations (5, 10, and 25 nM) and compared to untreated controls. Following seeding onto a laminin-coated Sylgard substrate, the administration of DEX was initiated on day 0 or day 6 in growth medium or on day 9 after the switch to differentiation medium and was sustained until the completion of SMU fabrication. During this process, total cell proliferation was measured with a BrdU assay, and myogenesis and structural advancement of muscle cells were observed through immunostaining for MyoD, myogenin, desmin, and α-actinin. After SMU formation, isometric tetanic force production was measured to quantify function. The histological and functional assessment of the SMU showed that the administration of 10 nM DEX beginning on either day 0 or day 6 yielded optimal SMUs. These optimized SMUs exhibited formation of advanced sarcomeric structure and significant increases in myotube diameter and myotube fusion index, compared with untreated controls. Additionally, the optimized SMUs matured functionally, as indicated by a fivefold rise in force production. In conclusion, we have demonstrated that the addition of DEX to our process of engineering skeletal muscle tissue improves myogenesis, advances muscle structure, and increases force production in the resulting SMUs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26790477      PMCID: PMC4800275          DOI: 10.1089/ten.TEA.2015.0545

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  30 in total

Review 1.  Engineering of muscle tissue.

Authors:  A D Bach; J Stem-Straeter; J P Beier; H Bannasch; G B Stark
Journal:  Clin Plast Surg       Date:  2003-10       Impact factor: 2.017

2.  Conditions for isolation and culture of porcine myogenic satellite cells.

Authors:  M E Doumit; R A Merkel
Journal:  Tissue Cell       Date:  1992       Impact factor: 2.466

3.  Bioreactors for guiding muscle tissue growth and development.

Authors:  R G Dennis; B Smith; A Philp; K Donnelly; K Baar
Journal:  Adv Biochem Eng Biotechnol       Date:  2009       Impact factor: 2.635

Review 4.  Skeletal muscle satellite cell cultures.

Authors:  R E Allen; C J Temm-Grove; S M Sheehan; G Rice
Journal:  Methods Cell Biol       Date:  1997       Impact factor: 1.441

5.  Engineered skeletal muscle units for repair of volumetric muscle loss in the tibialis anterior muscle of a rat.

Authors:  Keith W VanDusen; Brian C Syverud; Michael L Williams; Jonah D Lee; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2014-06-23       Impact factor: 3.845

6.  Effect of implantation on engineered skeletal muscle constructs.

Authors:  Michael L Williams; Tatiana Y Kostrominova; Ellen M Arruda; Lisa M Larkin
Journal:  J Tissue Eng Regen Med       Date:  2012-02-10       Impact factor: 3.963

7.  Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury.

Authors:  Benjamin T Corona; Catherine L Ward; Hannah B Baker; Thomas J Walters; George J Christ
Journal:  Tissue Eng Part A       Date:  2013-12-19       Impact factor: 3.845

8.  Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.

Authors:  C H Clegg; T A Linkhart; B B Olwin; S D Hauschka
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

9.  A standardized rat model of volumetric muscle loss injury for the development of tissue engineering therapies.

Authors:  Xiaowu Wu; Benjamin T Corona; Xiaoyu Chen; Thomas J Walters
Journal:  Biores Open Access       Date:  2012-12

10.  Generation of eX vivo-vascularized Muscle Engineered Tissue (X-MET).

Authors:  Silvia Carosio; Laura Barberi; Emanuele Rizzuto; Carmine Nicoletti; Zaccaria Del Prete; Antonio Musarò
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  15 in total

1.  A Comparison of Ovine Facial and Limb Muscle as a Primary Cell Source for Engineered Skeletal Muscle.

Authors:  Brittany L Rodriguez; Matthew H Nguyen; Rachel E Armstrong; Emmanuel E Vega-Soto; Phillip M Polkowski; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2019-10-07       Impact factor: 3.845

2.  Repairing Volumetric Muscle Loss in the Ovine Peroneus Tertius Following a 3-Month Recovery.

Authors:  Stoyna S Novakova; Brittany L Rodriguez; Emmanuel E Vega-Soto; Genevieve P Nutter; Rachel E Armstrong; Peter C D Macpherson; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2020-02-28       Impact factor: 3.845

3.  Label-Free, High-Throughput Purification of Satellite Cells Using Microfluidic Inertial Separation.

Authors:  Brian C Syverud; Eric Lin; Sunitha Nagrath; Lisa M Larkin
Journal:  Tissue Eng Part C Methods       Date:  2017-11-06       Impact factor: 3.056

4.  Quantitative, Label-Free Evaluation of Tissue-Engineered Skeletal Muscle Through Multiphoton Microscopy.

Authors:  Brian C Syverud; Mary-Ann Mycek; Lisa M Larkin
Journal:  Tissue Eng Part C Methods       Date:  2017-09-20       Impact factor: 3.056

5.  A Transgenic tdTomato Rat for Cell Migration and Tissue Engineering Applications.

Authors:  Brian C Syverud; Jonathan P Gumucio; Brittany L Rodriguez; Olga M Wroblewski; Shelby E Florida; Christopher L Mendias; Lisa M Larkin
Journal:  Tissue Eng Part C Methods       Date:  2018-04-10       Impact factor: 3.056

6.  The Maturation of Tissue-Engineered Skeletal Muscle Units following 28-Day Ectopic Implantation in a Rat.

Authors:  Brittany L Rodriguez; Shelby E Florida; Keith W VanDusen; Brian C Syverud; Lisa M Larkin
Journal:  Regen Eng Transl Med       Date:  2018-08-22

Review 7.  Growth Factors for Skeletal Muscle Tissue Engineering.

Authors:  Brian C Syverud; Keith W VanDusen; Lisa M Larkin
Journal:  Cells Tissues Organs       Date:  2016-11-09       Impact factor: 2.481

Review 8.  Development and application of human skeletal muscle microphysiological systems.

Authors:  George A Truskey
Journal:  Lab Chip       Date:  2018-10-09       Impact factor: 6.799

9.  Tart Cherry (Fruit of Prunus cerasus) Concentrated Powder (TCcp) Ameliorates Glucocorticoid-Induced Muscular Atrophy in Mice.

Authors:  Sae-Kwang Ku; Jong-Min Lim; Hyung-Rae Cho; Khawaja Muhammad Imran Bashir; Young Suk Kim; Jae-Suk Choi
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

10.  Impact of Human Epidermal Growth Factor on Tissue-Engineered Skeletal Muscle Structure and Function.

Authors:  Olga M Wroblewski; Emmanuel E Vega-Soto; Matthew H Nguyen; Paul S Cederna; Lisa M Larkin
Journal:  Tissue Eng Part A       Date:  2021-03-01       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.